Kestra Advisory Services’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,505
Closed -$101K 2772
2024
Q4
$101K Buy
12,505
+95
+0.8% +$783 ﹤0.01% 2569
2024
Q3
$101K Sell
12,410
-183
-1% -$1.21K ﹤0.01% 2464
2024
Q2
$87.8K Buy
+12,593
New +$95.3K ﹤0.01% 2532
2023
Q1
Sell
-16,227
Closed -$102K 2084
2022
Q4
$102K Sell
16,227
-2,994
-16% -$20.9K ﹤0.01% 2137
2022
Q3
$132K Buy
19,221
+2,854
+17% +$19.8K ﹤0.01% 1939
2022
Q2
$137K Buy
+16,367
New +$229K ﹤0.01% 1949
2022
Q1
Sell
-11,809
Closed -$326K 2008
2021
Q4
$326K Buy
+11,809
New +$316K ﹤0.01% 1560
2021
Q3
Sell
-9,296
Closed -$273K 2113
2021
Q2
$273K Buy
+9,296
New +$282K ﹤0.01% 1629
2021
Q1
Sell
-15,528
Closed -$311K 1860
2020
Q4
$311K Buy
+15,528
New +$290K ﹤0.01% 1454

Other funds holding BHC

Kestra Advisory Services's BHC Position: Q1 2025 in Review

Kestra Advisory Services sold out of Bausch Health (BHC) in Q1 2025, closing a stake of 12,505 shares — an estimated $101K sold.

Kestra Advisory Services first reported a position in BHC in Q4 2020 and held it in 9 quarters. The position peaked at $326K in Q4 2021. 230 funds tracked by Wall St. Rank hold BHC as of Q1 2025.

  • Kestra Advisory Services reported no remaining Bausch Health position as of Q1 2025 after selling out during the quarter.
  • Kestra Advisory Services sold 12,505 Bausch Health shares in Q1 2025, an estimated $101K.
  • Kestra Advisory Services first reported a position in Bausch Health in Q4 2020 and held it in 9 quarters.
  • Kestra Advisory Services's Bausch Health position peaked at $326K in Q4 2021.
  • 230 funds tracked by Wall St. Rank held Bausch Health as of Q1 2025.

Based on Kestra Advisory Services's 13F filing for Q1 2025, filed 14 May 2025.